T 0027/20 of 19.07.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T002720.20220719
- Date of decision
- 19 July 2022
- Case number
- T 0027/20
- Petition for review of
- -
- Application number
- 10792677.6
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- HETEROCYCLIC COMPOUNDS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHOLOGICAL DISORDERS
- Applicant name
- Alkermes Pharma Ireland Limited
- Opponent name
- Generics (UK) Ltd
- Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56European Patent Convention R 103(1)(a)European Patent Convention R 111(2)
- Keywords
- Inventive step
Substantial procedural violation - appealed decision reasoned (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the opposition division with the order to maintain the patent in amended form with the following claims and a description to be adapted thereto:
Claims 1 to 18 of the main request, filed as first auxiliary request with the statement of grounds of appeal
3. The appeal fee is reimbursed.